Tilray Brands, Inc.
Financial highlights
| Metric | FY 05/31/26 | FY 12/31/25 | FY 05/31/25 | FY 05/31/24 | FY 05/31/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.9 | — | $0.8 | $0.8 | $0.6 |
| Operating income | -$0.1 | — | -$2.3 | -$0.2 | -$1.4 |
| Net income | -$0.1 | — | -$2.2 | -$0.2 | -$1.5 |
| Balance Sheet | |||||
| Total debt | — | — | — | $0.1 | $0.4 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | -$0.1 | -$0.1 | -$<0.1 |
Shares outstanding 136.2M · Free float 88.9%
Annual filing data through FY ended May 31, 2026; float as of October 3, 2026.
Earnings
Other Coverage
October 14, 2026
Product Launch Watch
Micron Starts 1α DDR4; Tilray Launches CBD Oral Solution
October 14, 2026
Product Launch Watch
Micron Starts 1α DDR4; Tilray Launches CBD Oral Solution
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
July 22, 2026
Passive Ownership Watch
Passive Ownership Shifts in Index Holdings